KULEON LLC

From the company

Küleon is a drug discovery and development company leveraging proprietary, AI-based technology to identify novel serotonergic drugs for the targeted treatment of various neuropsychiatric diseases and disorders. It develops small molecule therapeutics for neuropsychiatric conditions modulated through serotonin receptors in the prefrontal cortex of the brain, targeting conditions including addiction, schizophrenia, obesity, pain, inflammation, and neurodegeneration.